Also, alteration in Aβ regulatory factors such as amyloid precursor protein (APP), beta-site APP-cleaving enzyme 1 (BACE1), presenilin (PS) 1 or 2, apolipoprotein E (APOE), neprilysin (NEP) and insulin-degrading enzyme (IDE), could play an important role in AD initiation and progression (Dong et al., 2012[17]). This evidence concerns the gene BACE1 and Alzheimer disease.